SIETES :: 93212 citas

Resultados de la búsqueda por GRIPE REFINAR BÚSQUEDA

1.

Godlee F. Covid-19: The lost lessons of Tamiflu. BMJ 2020;371:3 de diciembre. [Ref.ID 103804]

2.

Doshi P. Covid-19 vaccine trial protocols released. BMJ 2020:m4058. [Ref.ID 103766]

3.

Ward BJ, Makarkov A, Séguin A, Pillet S, Trépanier S, Dhaliwall J, Libman MD, Vesikari T, Landry N. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (=65 years): two multicentre, randomised phase 3 trials. Lancet 2020;396:13 de octubre. [Ref.ID 103743]

4.

Akkad W, Salem B, Freeman JW, Huntington MK. Longitudinally extensive transverse myelitis following vaccination with nasal attenuated novel influenza A(H1N1) vaccine. Arch Neurol 2020;67:agosto. [Ref.ID 103716]

5.

Ikematsu H, Hayden FG, Kawaguchi K, Kinoshita M, de Jong MD, Lee N, Takashima S, Noshi T, Tsuchiya K, Uehara T. Baloxavir marboxil for prophylaxis against influenza in household contacts. N Engl J Med 2020;383:23 de julio. [Ref.ID 103693]

6.

Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. BMJ 2020;369:8 de abril. [Ref.ID 103595]

7.

Anderson ML, Dobkin C, Gorry D. The effect of influenza vaccination for the elderly on hospitalization and mortality: An observational study with a regression discontinuity design. Ann Intern Med 2020;172:julio. [Ref.ID 103561]

8.

Anderson ML, Dobkin C, Gorry D. The effect of influenza vaccination for the elderly on hospitalization and mortality: an observational study with a regression discontinuity design. Ann Intern Med 2020;172:7 de abril. [Ref.ID 103545]

9.

Dyer O. Cochrane reviewer sues Roche for claiming Tamiflu could slow flu pandemic. BMJ 2020;368:31 de enero. [Ref.ID 103541]

10.

Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, Cook J, et al.. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Lancet 2020;395:4 de enero. [Ref.ID 103501]

11.

Rejón R. El director de un centro de vigilancia de la gripe en España recibió miles de euros de los fabricantes de vacunas contra el virus . eldiario.es 2019:13 de octubre. [Ref.ID 103195]

12.

Walsh LK, Donelle J, Dodds L, Hawken S, Wilson K, Benchimol EI, Chakraborty P, Guttmann A, Kwong JC, MacDonald NE, Sprague AE, Top KA, Walker MC, Web SW, Fell DB. Health outcomes of young children born to mothers who received 2009 pandemic H1N1 influenza vaccination during pregnancy: retrospective cohort study. BMJ 2019;366:10 de julio. [Ref.ID 103171]

13.

Modin D, Jorgensen ME, Gislason S, Jensen JS, Kober L, Claggett B, Hegde SM, Solomon SD, Torp-Pedersen C, Biering-Sorensen T. Influenza vaccine in heart failure cumulative number of vaccinations, frequency, timing, and survival: a Danish nationwide cohort study. Circulation 2018;139:10 de diciembre. [Ref.ID 102908]

14.

Anónimo. Recommended composition of influenza virus vaccines for use in the 2018-2019 Northern hemisphere influenza season. World Health Organization 2018:22 de febrero. [Ref.ID 102540]

15.

Wise J. Trivalent flu vaccine won’t protect against influenza B strain predominantly circulating. BMJ 2018;360:k78. [Ref.ID 102448]

16.

Anónimo. Health officials predict rough flu season, point to potentially less effective vaccine. DIA Daily 2017:17. [Ref.ID 102161]

17.

Zost SJ, Parkhouse K, Gumina ME, Kim K, Díaz Pérez S, Wilson PC, Treanor JJ, Sant AJ, Cobey S, Hensley SE. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains . Proceedings of the National Academy of Sciences of the United States of America 2017:6 de noviembre. [Ref.ID 102123]

18.

Donahue JG, Kieke BA, King JP, DeStefano F, Mascola MA, Irving SA, Cheetham TC, Glanz JM, Jackson LA, Klein NP, Naleway AL, Weintraub E, Belongia EA. Association of spontaneous abortion with receipt of inactivated influenza vaccine containing H1N1pdm09 in 2010–11 and 2011–12. Vaccine 2017;35:5314-22. [Ref.ID 102049]

19.

Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]

20.

Graner S, Svensson T, Beau A-B, Damase-Michel C, Engeland A, Furu K, Hviid A, Haberg SE, Molgaard-Nielsen D, Pasternak B, Kieler H. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. BMJ 2017;356:j629. [Ref.ID 101465]